3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit

The 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit is dedicated to current challenges, best practices and inside views of the future of microbiome-based products.

The 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit covers topics such as:

• CMC strategies to successfully develop live biotherapeutic products (LBPs)
• Emerging tech and developments to bring to the market efficient and safe microbiome products
• Critical considerations to design clinical trials for microbiome products GMP manufacturing and scale up considerations related to LBPs Commercialisation of microbiome-based diagnostics, therapies and service
• Regulatory perspective on probiotics, LBPs and FMTs

The 3rd Annual Microbiome: Regulatory, Quality Developments and Commercialization Summit brings together attendees involved or interested in:

• Alzheimer’s
• Ageing
• Atherosclerosis
• Antimicrobials
• Bacteriotherapy
• Autologous
• Biology
• Biofuels
• Bone Marrow Transplantation
• Bioreactors
• Cell Culture
• Bulk Material
• Clinical Trial
• Clinical Development
• Commercialisation
• CMO
• Cytokines
• Confocal Microscopy
• Drug Delivery
• Delivery
• Endocrinology
• Ecology
• Filtration
• Faecal Microbiota
• Fusobacteria
• FMT
• Genomics
• Gastrointestinal
• Gut-Brain Axis
• GMP
• IBS
• Hypertension
• In Vitro
• Immuno-Inflammation
• Inflammation
• IND
• Isolation
• Invention
• Lifesciences
• LBPs
• Lyophiliser
• Live Cell Therapeutics
• Metagenomic
• Medicinal Chemistry
• Microbiota
• Microbiology
• Mucosal Immunology
• Microganisms
• Nutraceuticals
• NASH
• Oncoviruses
• Nutrition
• Phages
• Pathogen
• Process Cultivation
• Prebiotics
• Quality Control
• Production
• Sequencing
• Regulatory
• Symbiosys
• Small Molecule
• Testing
• Synthetic Biology
• Vaccines
• Translational Sciences
• Western Blotting
• Analytical
• ALS
• Autoimmune
• Aseptic
• Biochemistry
• Bacteriology
• Biomarker
• Bioinformatics
• Bowel Syndrome
• Biotechnology
• CGMP
• Cell Biology
• CMC
• Clinical Study
• Computational Biology
• CNS
• Delivery
• Contract Manufacturing
• Dysbiosis
• DNA
• Epidemiology
• Eligobiotics
• Flow Cytometry
• Fermentation
• Gastroenterology
• Freeze Drying
• GI
• Genome Sequencing
• High Throughput Screening
• Gut
• ICH
• IBD
• In Vivo
• Immuno-Oncology
• Intellectual Property
• Infectious Disease
• Laboratory
• Investment
• Live Biotherapeutics
• Licensing
• Manufacturing
• Liver Disease
• Metatranscriptomics
• Mergers & Acquisition
• Microbiotherapy
• Microbiome
• Multiple Sclerosis
• Molecular Biology
• Nutrients
• Neurodegenerative
• Patent
• Obesity
• Pre-Clinical
• PCR
• Product Development
• Probiotics
• R&D
• QA
• Skin
• Safety
• Synbiotics
• SOP
• Tissue Culture
• Technology Transfer
• Viruses
• Ulcerative Colitis
• Yeast